The United States Supreme Court’s 2022 decision to overturn Roe v. Wade, the constitutional right to abortion, set off a series of changes to the way that abortions would be handled from state to state.
An attempt by a federal judge in Texas in April 2023 to revoke the Food and Drug Administration’s (FDA) approval for mifepristone, a drug approved by the FDA for medical termination of pregnancy through seven weeks gestation, then expanded to ten weeks gestation in 2016, was blocked by the U.S. Supreme Court that for now, preserves access to medication abortion using mifepristone. (Read more)
|